Board of Directors

Linda Bain

Ms. Bain is a Venture Partner at Atlas Venture, a venture capital firm focused on biotechnology. Ms. Bain previously served as Chief Operating Officer and Chief Financial Officer for Mariana Oncology (a Novartis company as of May 2024). She brings extensive experience in strategic planning, finance, transactions, operations, investor relations, corporate communications and program management.

She has raised nearly $1B in capital through venture, crossover rounds, initial public offerings and public equity financings over the past 10-plus years. Prior to Mariana Oncology, Linda served as Chief Financial Officer (CFO) of Codiak BioSciences, CFO of Avalanche Biotechnologies, and Vice President of Finance, Business Operations, and Treasurer at bluebird bio.

Ms. Bain also held senior roles at Genzyme Corporation, including Vice President of Finance, Global Manufacturing and Operations, and Vice President of Finance, Genzyme Genetics, and earlier in her career at Fidelity Investments, AstraZeneca, and Deloitte & Touche.

Ms. Bain currently serves on the Board of Directors of Autolus Therapeutics, a publicly-traded company, and Remix Therapeutics and Hemab Therapeutics, both private companies. She is a Certified Public Accountant and earned a Bachelor of Science in Accounting and Business Administration, as well as an Honors degree in Accounting and Business Administration, from the University of the Free State, Bloemfontein, South Africa.